Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation.

Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation. Abstract Text:

C Chueh,B D Kahan,

Transplantation tolerance is defined as permanent acceptance of an allograft without the need for nonspecific immunosuppressants, which predispose patients to infectious and neoplastic complications. Our approach uses chemically modified antigenic proteins to modify the first signal that triggers allorecognition. The first signal, which is generated by the trimolecular interaction between the T cell receptor, the antigen-presenting major histocompatibility complex (MHC) protein and the antigenic peptide, is distinguished from a second signal that results from the co-stimulatory interactions between T lymphocytes and antigen-presenting cells and the third signal that results from the stimulatory effects of cytokines. Previous studies in animal models have utilised pretransplant inoculation of the recipient with various types of donor-type cells, such as erythrocyte, bone marrow, transfectant or transgenic cells, or extracted transplantation antigens, which have been prepared by sonication, autolysis/proteolysis, detergent treatment or salt (3 mol/L KCl) extraction, which appears to be the most efficient method. Antigens extracted from natural cells induce tolerance in animal models when administered in pretreatment regimens via the intrathymic route (in conjunction with T cell depletion) or via the intravenous route (after preconditioning by total lymphoid irradiation). Exposure to synthetic allopeptides representing sequences from the hypervariable or the constant regions of either class I or class II MHC molecules produces variable effects on in vivo and in vitro alloimmune reactions. In addition to the interactions between peptides and MHC proteins and/or T cell receptor sites, at least some peptides act by binding to receptors of the heat shock protein family, thereby increasing intracellular calcium concentrations without inducing co-stimulatory signals, and/or by interacting directly with unique surface receptors on natural killer cells. However, several factors intrinsic to peptides may limit their use for tolerance induction in vivo. First, peptides are rapidly cleared by non-immunological mechanisms from the circulation, requiring the use of large quantities. Second, peptides are unable to contact the host system in a fashion that reflects the immunogenicity/tolerogenicity of the epitope on the native molecules. Third, peptides are unable to be processed by antigen-presenting cells. Our approach to tolerance induction uses allochimaeric MHC proteins, which are constructed by engrafting selected donor-type tolerogenic epitopes onto host-type MHC molecular backbones. When delivered in rat models via the intrathymic, intraportal or oral gavage route, allochimaeric class I MHC molecules induce immunodominant responses, namely they overwhelm all other responses toward foreign epitopes. Although most peritransplant antigen treatment regimens require concomitant administration of subtherapeutic doses of nonspecific immunosuppressants, some constructs induce tolerance without adjunctive immunosuppressive therapy. One critical requirement for tolerance induction by allochimaeric MHC antigens is the presence of host rather than third-party flanking amino acid sequences. The allochimaeric sequences seem to steer the host response toward tolerance by directly binding to immune cell receptors that deliver a 'self' signal (T cell receptor hypothesis), by directing endosomal catheptic activity to yield tolerogenic rather than immunogenic peptides (peptide hypothesis), or by altering the interactions in the tri-molecular complex, thereby interfering with the usual participation of the MHC molecule on the antigen-presenting cell (supertolerogen hypothesis).

Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation. Publishing Authors By Initials

C Chueh,BD Kahan,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: BioDrugs : clinical immunotherapeutics, biopharmac

VOLUME: 9

Page Numbers: 397-417

Journal Abbreviation:

ISSN: 1173-8804

DAY: 20

MONTH: May

YEAR: 1998

Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9705305

Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation.

AFFILIATION: Division of Immunology and Organ Transplantation, Department of Surgery, University of Texas - Houston Medical School, Houston, Texas, USA.

Country: New Zealand

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: BioDrugs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation Related Publications

• Acromegaly and pluriglandular dysfunction showing calcification of pituitary.
• Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common gamma-chain-dependent cytokine signals.
• Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantation.
• Atteinte myocardique primitive de la sclérodermie systémique.
• BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes.
• Bilirubin retinopathy.
• Casting-type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients.
• Domicilliary management of the subnormal child.
• Domicilliary management of the subnormal child.
• Empiric treatment of uncomplicated UTI in women: wasting money when more is not better.
• FTY 720 prevents ischemic reperfusion damage in rat kidneys.
• FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
• High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
• Mechanisms and amelioration of acute renal allograft failure in the cyclosporine era.
• New immunosuppressive agents.
• Paranoid states occurring in leaded-petrol handlers.
• Predominant primitive right ventricular involvement in systemic sclerosis.
• Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
• Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides.
• Problems related to anesthesia in geriatric surgery.
• Selection of lowly immunogenic and highly tolerogenic donor and recipient allochimeric class I major histocompatibility complex proteins.
• Sickle cell disease: a formidable enemy of the transplanter.
• Sirolimus and FTY720: new approaches to transplant immunosuppression.
• Spastic weak foot; a case report.
• Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen.
• Survey of parents, nurses, and school principals on their perceptions of the controversial role of schools in health promotion.
• The role of Stat5 in the induction of regulatory T cells in transplantation tolerance.
• Treatment of severely disturbed children. An experiment in residential management.
• Treatment of severely disturbed children. An experiment in residential management.
• [Hydroxyapatite microcrystals in synovial mitochondria in human and experimental rheumatism]